← Back to the feed

Scandens AG

History from 5 Oct 2021

UID

CHE-423.888.066

Legal form

AG

Canton

ZH

Founded

5 Oct 2021

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 8 Oct 2021 · legal date 5 Oct 2021

   Company formed

   Founded 5 Oct 2021

   SHAB HR01-1005307881 ↗

2. SHAB published 30 May 2022 · legal date 11 May 2022

   Name changed

   greenovate GmbH → Scandens GmbH

   SHAB HR02-1005483707 ↗

3. SHAB published 9 Jan 2024 · legal date 29 Dec 2023

   Converted to an AG

   GmbH → AG

   SHAB HR02-1005928699 ↗

4. SHAB published 9 Jan 2024 · legal date 29 Dec 2023

   Capital set in the conversion to an AG

   Not assessed

   Paid in cash

   Nominal capital

   20’000 → 100’000

   Shares

   — → 10’000’000

   New shares, % of post-step shares

   — (conversion to an AG)

   Umwandlung: Die Gesellschaft mit beschränkter Haftung hat das Stammkapital auf CHF 100'000.00 erhöht und wird gemäss Umwandlungsplan vom 29.12.2023 und Bilanz per 30.09.2023 mit Aktiven von CHF 236'870.47 und Passiven (Fremdkapital) von CHF 99'779.45 in eine Aktiengesellschaft umgewandelt. Rechtsform neu: Aktiengesellschaft. Aktienkapital neu: CHF 100'000.00 [bisher: CHF 20'000.00]. Liberierung Aktienkapital neu: CHF 100'000.00. Aktien neu: 10'000'000 Namenaktien zu CHF 0.01. Vinkulierung neu: Die Übertragbarkeit der Namenaktien ist nach Massgabe der Statuten beschränkt.

   SHAB HR02-1005928699 ↗

5. SHAB published 9 Jan 2024 · legal date 29 Dec 2023

   Name changed

   Scandens GmbH → Scandens AG

   SHAB HR02-1005928699 ↗

6. SHAB published 21 Nov 2025 · legal date 17 Nov 2025

   Capital increase

   ●●○Likely financing

   Paid in cash

   Nominal capital

   100’000 → 113’439.14

   Shares

   10’000’000 → 11’343’914

   New shares, % of post-step shares

   11.8% (1’343’914 new)

   Aktienkapital neu: CHF 113'439.14 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 113'439.14 [bisher: CHF 100'000.00]. Aktien neu: 11'343'914 Namenaktien zu CHF 0.01 [bisher: 10'000'000 Namenaktien zu CHF 0.01].

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.85 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006490820 ↗

7. SHAB published 5 Oct 2026 · legal date 23 Sep 2026

   Capital increase

   ○○○Capital increased

   Issued from conditional capital

   Nominal capital

   113’439.14 → 119’874.98

   Shares

   11’343’914 → 11’987’498

   New shares, % of post-step shares

   5.4% (643’584 new)

   Aktienkapital neu: CHF 119'874.98 [bisher: CHF 113'439.14]. Liberierung Aktienkapital neu: CHF 119'874.98 [bisher: CHF 113'439.14]. Aktien neu: 11'987'498 Namenaktien zu CHF 0.01 [bisher: 11'343'914 Namenaktien zu CHF 0.01].

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5
   • Shares issued out of conditional capital, as when options are exercised.−1.0

   Classifier score 0.10 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006773257 ↗

Published by 8 Oct 2026